A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2006
10/17/2006	US7122681 Displacement of solvent by vapor diffusion of water
10/17/2006	US7122680 3-Substituted oxindole β3 agonsists
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122675 Gamma secretase inhibitors
10/17/2006	US7122673 Cyclization of imines to form compounds such as 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one, used as nontoxic modulators of multidrug resistant cells; antitumor agents
10/17/2006	US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006	US7122668 Platinum complexes and their use in therapy
10/17/2006	US7122654 Hybrid; adjust vascular system permeability
10/17/2006	US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122579 Eye treatments using synthetic thyroid hormone compositions
10/17/2006	US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006	US7122558 Anticholinergic agents; chronic obstructive pulmonary diseases; incontinence; gastrointestinal disorders; antiulcer agents; cardiovascular disorders
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122541 LIVER CANCER; ADMINISTERING TAUROLIDINE, direct contact a liver tissue by perfusion in situ, to increase caspase activity in a cell
10/17/2006	US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006	US7122534 Aryl fused azapolycyclic compounds
10/17/2006	US7122528 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
10/17/2006	US7122525 Targeted therapeutics and uses thereof
10/17/2006	US7122523 Methods for inhibiting tumor cell proliferation
10/17/2006	US7122520 Nucleotide sequences coding polypeptide for use in the eating disorders
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122326 Central nervous system disorders; psychological disorders
10/17/2006	US7122213 Composed of squash extract mixed with onion extract, having hypotensive effect and an anti-diabetic effect
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006	CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/17/2006	CA2293808C Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
10/17/2006	CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/17/2006	CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/17/2006	CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
10/17/2006	CA2236357C 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands
10/17/2006	CA2148988C Filamentous bacteria extracts used as cosmetic agents against the ageing of skin
10/12/2006	WO2006107097A1 Nasal vaccine
10/12/2006	WO2006107059A1 Medicine for renal perfusion disorder
10/12/2006	WO2006107027A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia
10/12/2006	WO2006107019A1 Preventive or remedy for depression or anxiety neurosis
10/12/2006	WO2006106996A1 Gingival epithelial cell extension inhibitor
10/12/2006	WO2006106995A1 Matrix metalloproteinase inhibitor comprising ingredient extracted from amula
10/12/2006	WO2006106990A1 Composition for oral use
10/12/2006	WO2006106986A1 Agent for alleviating vascular insufficiency
10/12/2006	WO2006106983A1 Radiotherapy enhancer
10/12/2006	WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
10/12/2006	WO2006106887A1 Edible composition containing component extracted from salix sp. extract
10/12/2006	WO2006106839A1 METHOD FOR SCREENING AUXILIARY AGENT CAPABLE OF PROMOTING THE INDUCTION OF INTERFERON-α AND/OR -β (IFN-α/β) EXPRESSION
10/12/2006	WO2006106812A1 Propane-1,3-dion derivative or salt thereof
10/12/2006	WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	WO2006106721A1 Pyrimidine derivative having tyrosine kinase inhibitory effect
10/12/2006	WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding
10/12/2006	US20060229470 Calcium receptor-active molecules
10/12/2006	US20060229345 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
10/12/2006	US20060229343 Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
10/12/2006	US20060229342 TNF-a production inhibitors
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229324 Quinazolin-4-one derivatives
10/12/2006	US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/12/2006	US20060229319 For treatment of allergies; antihistamines
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229313 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/12/2006	US20060229290 Staurosporine derivatives for hypereosinophilic syndrome
10/12/2006	US20060229286 Therapy of diabetes
10/12/2006	US20060229273 High affinity oligonucleotide ligands to growth factors
10/12/2006	US20060229245 Lyophilized HGF preparations
10/12/2006	US20060229238 Sustained release of microcrystalline peptide suspensions
10/12/2006	US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006	US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy
10/12/2006	US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006	US20060228385 Sustained release of microcrystalline peptide suspensions
10/12/2006	US20060228354 Modified ADAMTS4 molecules and method of use thereof
10/12/2006	US20060228345 Osteogenesis promoter
10/12/2006	US20060228341 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/12/2006	DE102005015935A1 Herb tea mixture, useful as winter drink in cold seasons, comprises a tea mixture of ribwort plantain rich, sage and lemon juice, where herb components exist from fresh dried plants/plant parts or from a herb concentrate or a herb extract
10/12/2006	CA2603347A1 Oil-in-water emulsions of lignans that exhibit improved absorption rate
10/12/2006	CA2603030A1 Benzyloxypropylamine derivative
10/12/2006	CA2602467A1 Bcrp/abcg2 inhibitor
10/12/2006	CA2601988A1 Prophylactic or therapeutic agent for noctural conduct disorder associated with dementia
10/11/2006	EP1710582A2 Suppressor genes
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710304A1 Process for producing polymer composite of protein
10/11/2006	EP1710243A1 Therapeutic agent for vasospasm accompanying bypass operation
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1710231A1 CETP activity inhibitors
10/11/2006	EP1709976A1 Emt- inducing agents
10/11/2006	EP1709970A1 Human antibodies against EGFR, derived from immunized xenomice
10/11/2006	EP1709968A1 P2x receptor inhibitor

1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 1564